A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults with End-stage Kidney Disease on Hemodialysis with a Central Venous Catheter (Phase IIa)

Trial Identifier: D7480C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: December 2024
Primary Completion Date: October 2026
Study Completion Date: July 2027
Condition: Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AL Huntsville, AL, US, 35805
US, CA Chula Vista, CA, US, 91910
US, CA Glendale, CA, US, 91206
US, CA Granada Hills, CA, US, 91344
US, CA Los Angeles, CA, US, 90027
US, CA Northridge, CA, US, 91324
US, CA Northridge, CA, US, 91325
US, CA Oxnard, CA, US, 93036
US, CA Riverside, CA, US, 92503
US, CA San Dimas, CA, US, 91773
US, CA Tarzana, CA, US, 91356
US, CA Valencia, CA, US, 91355
US, CA Victorville, CA, US, 92392
US, CO Englewood, CO, US, 80110
US, FL Bradenton, FL, US, 34209
US, FL Coral Springs, FL, US, 33071
US, FL Hollywood, FL, US, 33024
US, FL Orlando, FL, US, 32806
US, FL Tampa, FL, US, 33603
US, IA Iowa City, IA, US, 52242
US, IL Chicago, IL, US, 60640
US, MD Baltimore, MD, US, 21225
US, MI Detroit, MI, US, 48202
US, MI Pontiac, MI, US, 48341
US, MO Kansas City, MO, US, 64111
US, MS Tupelo, MS, US, 38801
US, NC Winston Salem, NC, US, 27103
US, NE Lincoln, NE, US, 68510
US, NJ Jersey City, NJ, US, 07305
US, NM Albuquerque, NM, US, 87109
US, NY Ridgewood, NY, US, 11385
US, PA Bethlehem, PA, US, 18017
US, TX Beaumont, TX, US, 77706
US, TX Dallas, TX, US, 75246
US, TX Houston, TX, US, 77074
US, TX Mcallen, TX, US, 78503
US, TX San Antonio, TX, US, 78215